Calf Augmentation in Arizona
Calf Augmentation in Arizona section, includes general infrmation about Calf Augmentation Procedure, Calf Augmentation Arizona Local News, Calf Augmentation Arizona Surgeon Locator and other Calf Augmentation related material.
Calf Augmentation Procedure
This procedure offers a solution for those people that have underdeveloped calves or wish to augment them. The idea is to shape and size the calves by surgical insertion of implants. The implants are made of soft silicon and they come in different shapes and sizes. Before the operation your legs will be measured to select a proper implant for your needs. There is an alternative to implants. Calf augmentation can also be performed by liposuction of fat from other body parts and injecting it into the calves. This method is not suitable for people with no extra fat to be removed. Another problem is fat absorption that eventually occurs, sometimes creating not symmetric calves. Men and women can benefit from this procedure. Men usually want to increase the muscle bulk, giving them more masculine look and women wish to get more symmetrical appearance of their legs. This procedure also may help to correct some congenital defects, those include polio, spina bifida and clubfoot, all this conditions may be associated with undeveloped calves.
This procedure can be done with local or general anesthesia, and it usually lasts for an hour. During the operation the patient is laying on their back. A cut is made in the concavity behind the knee, then the skin is gently separated and a space is created. The implant is inserted above the muscles. After one leg is done the doctor performs the same on the other one. After the symmetry is confirmed the surgeon closes the cuts with stitches.
Every operation has its ricks. This one includes bleeding, infection and sometimes implants shrinkage and asymmetry.
After the surgery you may feel some degree of pain. Your doctor'll subscribe you for painkillers. At the first two days you'll be asked to raise your legs whenever you are sitting, this to reduce swelling. Afterwards, the bandages are removed and you are encouraged to walk more intensively to train your calve muscles. For about two weeks you'll fell like you're calves is been through excessive workout. Swelling and bruising also may appear, they are only temporary and will improve with time. You'll be able to go back to work after 7-10 days. You'll get detailed instructions from you're surgeon regarding the activities you should avoid, for example long walking, weight lifting and running. Usually, most of the patients are able to return to their daily activities after 4-6 weeks.
Other Calf Augmentation Procedures
All Body Procedures
Calf Augmentation Arizona (current)
Calf Augmentation Arizona Buttock Augmentation
Calf Augmentation Arizona Bariatric surgery
Calf Augmentation Arizona Liposuction
Calf Augmentation Arizona Body Contouring
More Arizona info...
Arizona Climate What To Wear
When visiting Arizona pack accordingly depending on the time of year and where you are traveling. Throughout the state dress is usually casual and comfortable, especially during the summer months. Very few restaurants require jackets and ties, however if you are planning on attending a cultural event or dining at a finer restaurant, consider bringing business casual attire as well.
During the summer, shorts and sandals are standard wear during the day, with a light sweater or jacket during the evenings at higher elevations. In the cooler months, temperatures can differ greatly from day to night, so consider bringing a sweater or jacket if traveling in the desert areas. At higher elevations in the north of the state, a winter jacket is recommended.
Hats, sunglasses and sunscreen should be used year-round.
Arizona The Grand Canyon One of the Seven Natural Wonders of the World, the Grand Canyon dominates the Northern Arizona landscape. Stretching 277 miles across the high plateaus and plunging up to 6,000 feet into the arid plateau, the canyon was shaped and carved by the constant motion of the Colorado River. The Grand Canyon features three or four eras of geological time as well several layers of fossil records, several variety rock types, numerous caves and several major ecosystems.
Plastic Surgery News...
- Nowhere is the principle of "strength in numbers" more apparent than in the collective power of microbes: despite their simplicity, these one-cell organisms -- which number about 5 million trillion trillion strong (no, that is not a typo) on Earth -- affect virtually every ecological process, from the decay of organic material to the production of oxygen.
- BioSpace has reported briefly on Phase III data for retigabine, a first-in-class neuronal potassium channel opener which is in development as an adjunct in the treatment of adult epilepsy patients with refractory partial-onset seizures.
The double-blind trial – RESTORE 1 (Retigabine Efficacy and Safety Trials for Partial Onset Epilepsy) – randomised 306 adults who were experiencing refractory partial-onset seizures despite receiving stable doses of up to three anti-epileptics to additional treatment with retigabine (400mg TDS; n=151) or placebo (n=150). Study duration was 32 weeks including 8 weeks baseline phase, 6 weeks titration phase, 12 weeks maintenance phase and 6 weeks transition phase. Only brief details of the study are included in the BioSpace abstract which prevents a full evaluation of the findings; however the following results were reported:
• The median reduction in 28-day total partial seizure frequency was 44.3% in the retigabine group and 17.5% in the placebo group (p<0.0001)
• The median reduction in 28-day total partial seizure frequency during the maintenance phase was 54.5% versus 18.9%, respectively (p<0.0001)
• The responder rate (at least a 50% reduction in 28-day total partial seizure frequency) was 45.0% versus 18.0%, respectively (p<0.0001)
• The responder rate during the maintenance phase was 55.5% versus 22.6%, respectively (p<0.0001)
Results from RESTORE 2, the second pivotal Phase III clinical trial studying lower doses of retigabine, are expected during the second quarter of 2008. The company anticipate filing a Marketing Authorization Application (MAA) to the EMEA before the end of the year.